Atrial fibrillation (AF) in younger adults is a highly heterogeneous condition, encompassing a broad clinical spectrum and associated with markedly different cardiovascular outcomes.
We aimed to identify distinct clinical–echocardiographic phenotypes of AF in patients aged <65 years and to evaluate their a...
A. Rigutini, T. Bucci, E. Tartaglia et al.· European Heart Journal· 0 citations
Chronic kidney disease (CKD) is common in heart failure (HF) and is associated with adverse outcomes. However, its prognostic impact and the effects of contemporary HF therapies—including angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter-2 inhibitors (SGLT2i)—on renal function rem...
E. Tartaglia, N. Bonini, M. Mantovani et al.· European Heart Journal· 0 citations
BACKGROUND AND AIM
Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium-glucose cotransporter-2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with...
Leandra Serio, M. Rossi, A. Askarinejad et al.· Diabetes, obesity and metabo...· 0 citations
Three distinct phenotypic clusters were identified, each with heterogeneous clinical characteristics and outcomes, underscoring the need for more individualised, phenotype-informed management strategies in this complex patient population.
A. Askarinejad, T. Bucci, Enrico Tartaglia et al.· European journal of internal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.